Stock listing
17Q1 Stock Price, News, Filings & Events — Pharmaron Beijing Co., Ltd. Class A
Selected listing: 17Q1 · FWB · EUR · DE
This page tracks Pharmaron Beijing Co., Ltd. Class A's 17Q1:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 17Q1:FWB. 17Q1:FWB is the stock-level entry point for investors researching Pharmaron Beijing Co., Ltd. Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 17Q1:FWB
- Asset type
- Stock
- Market cap
- $10.27B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- FWB
- Currency
- EUR
Pharmaron Beijing Co., Ltd. Class A 17Q1:FWB stock context
This page tracks Pharmaron Beijing Co., Ltd. Class A's 17Q1:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 17Q1:FWB. 17Q1:FWB is the stock-level entry point for investors researching Pharmaron Beijing Co., Ltd. Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Pharmaron Beijing Co., Ltd. Class A
Pharmaron Acquires Biortus in China
October 28, 2025
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
March 29, 2023
Pharmaron Acquires Commercial API Manufacturing Facility in the United States
May 24, 2022
Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC
January 16, 2022
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm
January 9, 2022
Research Pharmaron Beijing Co., Ltd. Class A
Pharmaron Beijing Co., Ltd. Class A investor report
Review AI stock analysis and investor report context for 17Q1:FWB.
Pharmaron Beijing Co., Ltd. Class A company profile
View the public company page for Pharmaron Beijing Co., Ltd. Class A on 6ix.
Pharmaron Beijing Co., Ltd. Class A news
Read company news and market updates connected to Pharmaron Beijing Co., Ltd. Class A.
Pharmaron Beijing Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Pharmaron Beijing Co., Ltd. Class A.
Alternate listings
300759:SZSE
CN · CNY
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
3759:HKEX
HK · HKD
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
A2PV00:LS
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
A2PV00:LSX
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
17Q1:GETTEX
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
17Q1:DUS
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
PHBBF:OTC
US · USD
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
17Q1:SWB
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.
17Q1:TRADEGATE
DE · EUR
Alternate listing for Pharmaron Beijing Co., Ltd. Class A; the primary context on this page is 17Q1:FWB.